162 related articles for article (PubMed ID: 37118443)
1. Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
Maleki H; Doostan M; Farzaei MH; Seifi P; Miraghaee S; Doostan M
AAPS PharmSciTech; 2023 Apr; 24(5):112. PubMed ID: 37118443
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis.
Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M
Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial.
Amiri M; Navabi J; Shokoohinia Y; Heydarpour F; Bahrami G; Behbood L; Derakhshandeh P; Momtaz S; Farzaei MH
Complement Ther Med; 2019 Aug; 45():262-268. PubMed ID: 31331572
[TBL] [Abstract][Full Text] [Related]
4. Dual Functional Eudragit
Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M
Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
[TBL] [Abstract][Full Text] [Related]
5. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
6. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats.
Ahmed O; Abdel-Halim M; Farid A; Elamir A
Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389
[TBL] [Abstract][Full Text] [Related]
7. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema.
Dong K; Deng SJ; He BY; Guo ZY; Guan ZL; Leng X; Ma RR; Wang DY; Xing JF; You CY
Drug Des Devel Ther; 2023; 17():191-207. PubMed ID: 36718245
[TBL] [Abstract][Full Text] [Related]
9. Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment.
Zhang W; Zhang X; Lv X; Qu A; Liang W; Wang L; Zhao P; Wu Z
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542929
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
11. Preparing simvastatin nanoparticles by a combination of pH-sensitive and timed-release approaches for the potential treatment of ulcerative colitis.
Fardafshari F; Taymouri S; Minaiyan M; Tavakoli N
J Biomater Appl; 2022 Nov; 37(5):859-871. PubMed ID: 35999010
[TBL] [Abstract][Full Text] [Related]
12. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
[TBL] [Abstract][Full Text] [Related]
13. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis.
Ahmad A; Ansari MM; Mishra RK; Kumar A; Vyawahare A; Verma RK; Raza SS; Khan R
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111582. PubMed ID: 33321628
[TBL] [Abstract][Full Text] [Related]
14. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment.
Zhang Y; Ma R; You C; Leng X; Wang D; Deng S; He B; Guo Z; Guan Z; Lei H; Yu J; Zhou Q; Xing J; Dong Y
Carbohydr Polym; 2023 Aug; 313():120884. PubMed ID: 37182972
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites.
Dong K; Zhang Y; Ji HR; Guan ZL; Wang DY; Guo ZY; Deng SJ; He BY; Xing JF; You CY
Int J Nanomedicine; 2024; 19():993-1016. PubMed ID: 38299194
[TBL] [Abstract][Full Text] [Related]
17. Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis.
El-Dakroury WA; Zewail MB; Asaad GF; Abdallah HMI; Shabana ME; Said AR; Doghish AS; Azab HA; Amer DH; Hassan AE; Sayed AS; Samra GM; Sallam AM
Eur J Pharm Biopharm; 2024 Mar; 196():114205. PubMed ID: 38311187
[TBL] [Abstract][Full Text] [Related]
18. Formulation and optimization of theophylline-loaded enteric-coated spanlastic nanovesicles for colon delivery; Ameliorate acetic acid-induced ulcerative colitis.
Barakat EH; Akl MA; Ibrahim MF; Mohamed Dawaba H; Afouna MI
Int J Pharm; 2023 Aug; 643():123253. PubMed ID: 37473974
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
Xiong M; Li Y; He H; Hao S; Fang P; Xu M; Chen Y; Chen Y; Yu S; Hu H
Eur J Pharm Biopharm; 2023 Aug; 189():152-164. PubMed ID: 37336365
[TBL] [Abstract][Full Text] [Related]
20. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
Samprasit W; Opanasopit P; Chamsai B
J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
